Teicoplanin Dosing
For standard infections, teicoplanin requires a loading dose of 6 mg/kg given three times every 12 hours, followed by 6 mg/kg once daily maintenance dosing, with dose adjustments based on renal function; however, for serious infections like endocarditis or septic arthritis, higher loading doses of 12 mg/kg three times every 12 hours are necessary to achieve therapeutic trough concentrations of ≥20 mg/L. 1
Standard Dosing Regimen
Loading Dose Strategy
- Three loading doses of 6 mg/kg every 12 hours for standard infections 1
- Three loading doses of 12 mg/kg every 12 hours for serious infections (S. aureus endocarditis or septic arthritis) 1
- Loading doses are critical because teicoplanin has a long half-life and requires rapid achievement of therapeutic concentrations 1
Maintenance Dosing
- 6 mg/kg once daily for standard infections with normal renal function (GFR >90 mL/min) 1
- 12 mg/kg once daily for endocarditis or septic arthritis 1
Renal Function-Based Adjustments
The dosing interval must be extended based on glomerular filtration rate, as renal function is the primary determinant of teicoplanin clearance 1, 2, 3:
- GFR >90 mL/min: 24-hour interval 1
- GFR 50-90 mL/min: 24-hour interval 1
- GFR 10-50 mL/min: 48-hour interval 1
- GFR <10 mL/min: 72-hour interval 1
Special Populations
Hemodialysis Patients
- Loading dose: 12 mg/kg 1
- Maintenance: 6 mg/kg on day 2 and day 3, then 6 mg/kg weekly 1
- For endocarditis cases, additional doses on days 5,12, and 17 may be required 1
Pediatric Patients
- Loading: Three doses of 10 mg/kg every 12 hours 1
- Maintenance: 6-10 mg/kg once daily (total 40 mg/kg/24h) 1
- Premature infants (PMA ≤28 weeks) require decreased doses 4
- Children with normal renal function (eGFR ≥90 mL/min/1.73 m²) may require increased doses 4
Critically Ill and ICU Patients
Recent evidence demonstrates that standard dosing is frequently inadequate in critically ill patients 2, 5, 3:
- Loading doses of 12-15 mg/kg every 12 hours for 3-5 doses are recommended 2, 5, 3
- Maintenance doses of 12-15 mg/kg adjusted by renal function (every 24-72 hours) 2, 3
- Higher doses are necessary because critically ill patients have increased volumes of distribution and altered pharmacokinetics 2, 5
Therapeutic Drug Monitoring
When to Monitor
Unlike vancomycin, routine monitoring is not required for standard infections 1. However, monitoring is indicated for:
- S. aureus endocarditis or septic arthritis (target trough ≥20 mg/L) 1
- Patients with major burns 1
- Intravenous drug users 1
- Rapidly changing renal function 1
- Critically ill patients 2, 5, 3
Target Concentrations
- Standard infections: Trough ≥10 mg/L 1
- Serious infections (endocarditis, septic arthritis): Trough ≥20 mg/L 1, 6
- Febrile neutropenia: Early trough (48h) ≥18.85 mg/L predicts treatment success 7
- Target AUC₀₋₂₄/MIC ≥610 for optimal outcomes 2
Timing of Monitoring
- Day 3 (48 hours post-loading) for early assessment in high-risk patients 7
- Day 4-5 for standard monitoring 2, 3
- Follow-up at steady state if initial concentrations are subtherapeutic 2
Critical Considerations
Common Pitfalls
- Standard 400 mg dosing is inadequate for most patients, particularly those with normal renal function or serious infections 2, 5, 3
- Body weight significantly affects teicoplanin concentrations in patients receiving optimal loading doses 5, 8
- Low serum albumin (<29 g/L) reduces total but not unbound teicoplanin concentrations, potentially leading to underdosing if only total concentrations are monitored 8
- High creatinine clearance (>90 mL/min) is associated with failure to achieve target concentrations with standard dosing 8, 3